Selkoe DJ. Alzheimer’s Disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–66.

Article  CAS  PubMed  Google Scholar 

Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s Disease at 25 years. EMBO Mol Med. 2016;8:595.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sims R, van der Lee SJ, Naj AC, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s Disease. Nat Genet. 2017;49:1373–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalmasso MC, Brusco LI, Olivar N, et al. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s Disease. Transl Psychiatry. 2019;9:1–6.

Article  Google Scholar 

Efthymiou AG, Goate AM. Late onset Alzheimer’s Disease genetics implicates microglial pathways in Disease risk. Mol Neurodegener. 2017;12:1–12.

Article  Google Scholar 

McQuade A, Blurton-Jones M. Microglia in Alzheimer’s Disease: exploring how Genetics and phenotype influence risk. J Mol Biol. 2019;431:1805–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scheiblich H, Trombly M, Ramirez A, et al. Neuroimmune connections in aging and neurodegenerative Diseases. Trends Immunol. 2020;41:300–12.

Article  CAS  PubMed  Google Scholar 

Wightman DP, Jansen IE, Savage JE, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s Disease. Nat Genet. 2021;53:1276–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s Disease. Nat Genet. 2013;45:1452–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunkle BW, Grenier-Boley B, Sims R, et al. Genetic meta-analysis of diagnosed Alzheimer’s Disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019;51:414–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bellenguez C, Küçükali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer’s Disease and related Dementias. Nat Genet. 2022;54:412–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prinz M, Jung S, Priller J. Microglia Biology: one century of evolving concepts. Cell. 2019;179:292–311.

Article  CAS  PubMed  Google Scholar 

Yvanka de Soysa T, Therrien M, Walker AC, et al. Redefining microglia states: lessons and limits of human and mouse models to study microglia states in neurodegenerative Diseases. Semin Immunol. 2022;60:101651.

Article  CAS  PubMed  Google Scholar 

McNamara NB, Munro DAD, Bestard-Cuche N, et al. Microglia regulate central nervous system myelin growth and integrity. Nature. 2023;613:120–9.

Article  CAS  PubMed  Google Scholar 

Stevens B, Allen NJ, Vazquez LE, et al. The classical complement Cascade mediates CNS synapse elimination. Cell. 2007;131:1164–78.

Article  CAS  PubMed  Google Scholar 

Liddelow SA, Marsh SE, Stevens B. Microglia and astrocytes in Disease: dynamic duo or partners in crime? Trends Immunol. 2020;41:820–35.

Article  CAS  PubMed  Google Scholar 

Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Y-J, Au NPB, Ma CHE. Functional and phenotypic diversity of Microglia: implication for Microglia-based therapies for Alzheimer’s Disease. Front Aging Neurosci. 2022; 14.

Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821–32.

Article  CAS  PubMed  Google Scholar 

Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immune–metabolic viewpoint for age-related Diseases. Nat Rev Endocrinol. 2018;14:576–90.

Article  CAS  PubMed  Google Scholar 

Hou Y, Dan X, Babbar M, et al. Ageing as a risk factor for neurodegenerative Disease. Nat Rev Neurol. 2019;15:565–81.

Article  PubMed  Google Scholar 

Coppé JP, Desprez PY, Krtolica A, et al. The Senescence-Associated Secretory phenotype: the Dark side of Tumor suppression. Annu Rev Pathol. 2010;5:99–118.

Article  PubMed  PubMed Central  Google Scholar 

Wang WY, Tan MS, Yu JT, et al. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s Disease. Ann Transl Med. 2015;3:136.

PubMed  PubMed Central  Google Scholar 

Higginbotham L, Ping L, Dammer EB et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease. Sci Adv.; 6.

Brosseron F, Krauthausen M, Kummer M, et al. Body fluid cytokine levels in mild cognitive impairment and Alzheimer’s Disease: a comparative overview. Mol Neurobiol. 2014;50:534.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kinney JW, Bemiller SM, Murtishaw AS, et al. Inflammation as a central mechanism in Alzheimer’s Disease. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2018;4:575–90.

Google Scholar 

Paolicelli RC, Sierra A, Stevens B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holling TM, Schooten E, van den Elsen PJ. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum Immunol. 2004;65:282–90.

Article  CAS  PubMed  Google Scholar 

Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s Disease. J Cell Biol. 2018;217:459–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou J, Chen Y, Grajales-Reyes G, et al. TREM2 dependent and Independent functions of microglia in Alzheimer’s Disease. Mol Neurodegener. 2022;17:1–19.

Article  Google Scholar 

Zhao Y, Wu X, Li X, et al. TREM2 is a receptor for β-Amyloid that mediates microglial function. Neuron. 2018;97:1023–1031e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bianchin MM, Martin KC, de Souza AC, et al. Nasu–Hakola Disease and primary microglial dysfunction. Nat Rev Neurol. 2010;6:523–3.

Article  PubMed  Google Scholar 

Kleinberger G, Yamanishi Y, Suárez-Calvet M, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6:23.

Article  Google Scholar 

Mazaheri F, Snaidero N, Kleinberger G, et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 2017;18:1186–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Cella M, Mallinson K, et al. TREM2 lipid sensing sustains the Microglial response in an Alzheimer’s Disease Model. Cell. 2015;160:1061–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jay TR, Miller CM, Cheng PJ, et al. TREM2 deficiency eliminates TREM2 + inflammatory macrophages and ameliorates pathology in Alzheimer’s Disease mouse models. J Exp Med. 2015;212:287–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parhizkar S, Arzberger T, Brendel M, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jay TR, Hirsch AM, Broihier ML, et al. Disease Progression-Dependent effects of TREM2 Deficiency in a mouse model of Alzheimer’s Disease. J Neurosci. 2017;37:637–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhandapani R, Neri M, Bernhard M, et al. Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer’s Disease. Cell Rep. 2022;39:110883.

Article  CAS